BASKING RIDGE, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) — electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced Chief Executive Officer, Frank Amato and Chief Science & Strategy Officer, JP Errico will present at NobleConXV – Noble Capital Markets’ Fifteenth Annual Investor Conference in Fort Lauderdale, Florida – on Tuesday, January 29, 2019 at 10:30 a.m. Eastern Standard Time.

Interested parties may access an archived webcast of the presentation on the “Investors” section of the company’s website at: www.electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The Company’s initial targets are the acute treatment of migraine and episodic cluster headache and the prevention of cluster headache.

For more information, visit www.electrocore.com.  

Contacts
Investors:
Hans C Vitzthum
LifeSci Advisors
617-535-7743
[email protected]

or

Media:
Alexandra Canale
GCI Health
(617) 921-9353
[email protected]